These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23344680)

  • 21. Prevalence of diabetes and impaired glucose tolerance in 64-year-old Swedish women: experiences of using repeated oral glucose tolerance tests.
    Brohall G; Behre CJ; Hulthe J; Wikstrand J; Fagerberg B
    Diabetes Care; 2006 Feb; 29(2):363-7. PubMed ID: 16443888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of retinopathy in people with diabetes, impaired glucose tolerance, and normal glucose tolerance.
    Rajala U; Laakso M; Qiao Q; Keinänen-Kiukaanniemi S
    Diabetes Care; 1998 Oct; 21(10):1664-9. PubMed ID: 9773727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the Finnish Diabetes Risk Score as a screening tool for impaired fasting glucose, impaired glucose tolerance and undetected diabetes.
    Tankova T; Chakarova N; Atanassova I; Dakovska L
    Diabetes Res Clin Pract; 2011 Apr; 92(1):46-52. PubMed ID: 21242013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired glucose regulation in adults in Jamaica: who should have the oral glucose tolerance test?
    Sargeant LA; Boyne MS; Bennett FI; Forrester TE; Cooper RS; Wilks RJ
    Rev Panam Salud Publica; 2004 Jul; 16(1):35-42. PubMed ID: 15333264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fasting plasma glucose as initial screening for diabetes and prediabetes in irish adults: The Diabetes Mellitus and Vascular health initiative (DMVhi).
    Sinnott M; Kinsley BT; Jackson AD; Walsh C; O'Grady T; Nolan JJ; Gaffney P; Boran G; Kelleher C; Carr B
    PLoS One; 2015; 10(4):e0122704. PubMed ID: 25874867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance.
    Hu Y; Liu W; Chen Y; Zhang M; Wang L; Zhou H; Wu P; Teng X; Dong Y; Zhou Jw; Xu H; Zheng J; Li S; Tao T; Hu Y; Jia Y
    Acta Diabetol; 2010 Sep; 47(3):231-6. PubMed ID: 19760291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of The World Health Organization (WHO) two-step strategy and OGTT for diabetes mellitus screening.
    Adam JM; Tarigan NP
    Acta Med Indones; 2004; 36(1):3-7. PubMed ID: 15931695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prevalence of abnormal glucose tolerance in hypertensive patients].
    Rubio-Guerra AF; Rodríguez-López L; Lozano-Nuevo JJ; Vargas-Ayala G; Beltrán-Soto JM; Durán-Salgado MB
    Rev Med Inst Mex Seguro Soc; 2014; 52(4):404-7. PubMed ID: 25078742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucose Intolerance after a Recent History of Gestational Diabetes Based on the 2013 WHO Criteria.
    Benhalima K; Jegers K; Devlieger R; Verhaeghe J; Mathieu C
    PLoS One; 2016; 11(6):e0157272. PubMed ID: 27285104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in the Kashmir Valley of the Indian subcontinent.
    Zargar AH; Khan AK; Masoodi SR; Laway BA; Wani AI; Bashir MI; Dar FA
    Diabetes Res Clin Pract; 2000 Feb; 47(2):135-46. PubMed ID: 10670914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral glucose tolerance testing as a complement to fasting plasma glucose in screening for type 2 diabetes: population-based cross-sectional analyses of 146 000 health examinations in Västerbotten, Sweden.
    Rosén A; Otten J; Stomby A; Vallin S; Wennberg P; Brunström M
    BMJ Open; 2022 Jun; 12(6):e062172. PubMed ID: 35676014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance of the Finnish Diabetes Risk Score and a Simplified Finnish Diabetes Risk Score in a Community-Based, Cross-Sectional Programme for Screening of Undiagnosed Type 2 Diabetes Mellitus and Dysglycaemia in Madrid, Spain: The SPREDIA-2 Study.
    Salinero-Fort MA; Burgos-Lunar C; Lahoz C; Mostaza JM; Abánades-Herranz JC; Laguna-Cuesta F; Estirado-de Cabo E; García-Iglesias F; González-Alegre T; Fernández-Puntero B; Montesano-Sánchez L; Vicent-López D; Cornejo-Del Río V; Fernández-García PJ; Sánchez-Arroyo V; Sabín-Rodríguez C; López-López S; Patrón-Barandio P; Gómez-Campelo P;
    PLoS One; 2016; 11(7):e0158489. PubMed ID: 27441722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetes Screening in Canada (DIASCAN) Study: prevalence of undiagnosed diabetes and glucose intolerance in family physician offices.
    Leiter LA; Barr A; Bélanger A; Lubin S; Ross SA; Tildesley HD; Fontaine N;
    Diabetes Care; 2001 Jun; 24(6):1038-43. PubMed ID: 11375367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detecting diabetes and impaired glucose tolerance in patients with atherosclerotic peripheral arterial disease.
    Green FC; Levison R; Newton DJ; Littleford R; Stonebridge PA; Belch JJ
    Int Angiol; 2012 Apr; 31(2):125-8. PubMed ID: 22466976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility of antenatal clinical factors for prediction of postpartum outcomes in women with gestational diabetes mellitus (GDM).
    Ingram ER; Robertson IK; Ogden KJ; Dennis AE; Campbell JE; Corbould AM
    Aust N Z J Obstet Gynaecol; 2017 Jun; 57(3):272-279. PubMed ID: 27549600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High prevalence of steroid-induced glucose intolerance with normal fasting glycaemia during low-dose glucocorticoid therapy: an oral glucose tolerance test screening study.
    Nowak KM; Rdzanek-Pikus M; Romanowska-Próchnicka K; Nowakowska-Płaza A; Papierska L
    Rheumatology (Oxford); 2021 Jun; 60(6):2842-2851. PubMed ID: 33254223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prevalence of glucometabolic abnormalities in connection with myocardial infarction in a Danish coronary care unit].
    Egstrup M; Henriksen FL; Høfsten DE; Jensen BK; Hangaard J; Egstrup K
    Ugeskr Laeger; 2008 Mar; 170(11):942-6. PubMed ID: 18397622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-partum reclassification of glucose tolerance in women previously diagnosed with gestational diabetes mellitus.
    Costa A; Carmona F; Martinez-Roman S; Quintó L; Levy I; Conget I
    Diabet Med; 2000 Aug; 17(8):595-8. PubMed ID: 11073181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fasting plasma glucose and glycated haemoglobin in the screening of diabetes and impaired glucose tolerance.
    Mannucci E; Ognibene A; Sposato I; Brogi M; Gallori G; Bardini G; Cremasco F; Messeri G; Rotella CM
    Acta Diabetol; 2003 Dec; 40(4):181-6. PubMed ID: 14740278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Value of continuous glucose monitoring in screening for diabetes in cystic fibrosis].
    Khammar A; Stremler N; Dubus JC; Gross G; Sarles J; Reynaud R
    Arch Pediatr; 2009 Dec; 16(12):1540-6. PubMed ID: 19854630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.